Novartis International AG /
Novartis completes divestiture of influenza vaccines business to CSL Limited for
USD 275 million
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
* CSL Limited acquired influenza v ...
↧